Shao, E H
Sivagnanavel, V
Dabbagh, A
Dave, R
Tempest-Roe, S
Tam, F W K
Taylor, S R
Article History
Received: 19 July 2014
Accepted: 9 December 2014
First Online: 6 February 2015
Competing interests
: SRJT is supported by the UK National Institute of Health Research. SRJT has received advisory board fees from Novartis AG. ST-R receives funding from BBSRC and GlaxoSmithKline. FWKT receives funding from Baxter.